Previous Page  35 / 47 Next Page
Information
Show Menu
Previous Page 35 / 47 Next Page
Page Background

Page 95

conferenceseries

.com

Volume 6

Journal of Infectious Diseases and Therapy

ISSN: 2332-0877

Infection Congress 2018

March 01-02, 2018

March 01-02, 2018 Berlin, Germany

5

th

International Congress on

INFECTIOUS DISEASES

J Infect Dis Ther 2018, Volume 6

DOI: 10.4172/2332-0877-C1-039

Promastigote existence in infected lesions of cutaneous leishmaniasis

Mohammed Wael Daboul

Damascus University, Saudi Arabia

L

eishmaniasis is an endemic parasitic disease in 88 countries. It is widely distributed throughout the world, caused by vector-

borne, obligate, intracellular hemoflagellates of the genus Leishmania. The parasite continues its life cycle transforming to

promastigote in the mid gut of the sand fly vector and is transmitted to the human host in the form of promastigote via the

bite of the sand fly. Other less encountered forms of transmission are because of a laboratory accident, direct person-to-person

transmission, organ transplant and blood transfusion. There is evidence that leishmaniasis may be transmitted either in utero

or during the peripartum period. The promastigote form is considered the primary organism of disease transmission between

the vector and the host. By not having a chance to continue its life cycle and transform into promastigote within the vector

sand fly when considering the many different routes of transmission other than the sand fly bites, it is reasonable to assume

an alternative possible existence of the promastigote form of the parasite in the infected lesion of cutaneous leishmaniasis

in human host. The information presented indicates that a real transformation of amastigote to promastigote form occurs

within the human host cutaneous lesion in the extracellular fluid after the macrophage membrane eruption and the amastigote

release. New techniques are recommended for future studies to confirm these findings including real-time polymerase chain

reaction (PCR) and applying the immunohistochemistry techniques using a novel monoclonal antibody (mAb) against the

parasite flagellate (promastigote form) cell wall component

.

mowaeldaboul@yahoo.com